Surrey Heartlands

Joint Formulary & PAD

Ondansetron hydrochloride - Nausea and vomiting

You are here : Home > Formulary Search > Ondansetron hydrochloride - Nausea and vomiting

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Injection
  • Oral solution
  • Tablets
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Off-label use. Only licensed for post-operative and chemotherapy-induced nausea and vomiting
 

Status 2

Red
Formulations :
  • Oro-dispersible
  • Orodispersible films
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Un
Restrictions / Comments :
Important
Orodispersible preparations reserved for use when ordinary tablets are not suitable.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Ondansetron hydrochloride
Indication :
Nausea and vomiting
Group Name :
Keywords :
Brand Names Include :
Important Information :
Non-specific nausea / vomiting. See separate entries for pregnancy, post-operative and chemo-related indications.
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0
Traffic Light Entries :
2

Other Indications

Below are listed other indications that Ondansetron hydrochloride is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Nausea and vomiting .

Committee Recommendations (1)

06 Nov 24 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.